Grant Details
Grant Number: |
5U01CA049449-09 Interpret this number |
Primary Investigator: |
Speizer, Frank |
Organization: |
Brigham And Women'S Hospital |
Project Title: |
Biochemical Markers in the Nurses Health Study Cohort |
Fiscal Year: |
1998 |
Abstract
We propose to analyze blood samples in a "nested" case-control manner from
the 32,825 participants in the Nurses' Health Study (NHS) who provided
samples in 1989-1990 and were 43 to 69 years of age at that time. The
samples have been stored at less than or equal to 130 degrees C, in liquid
nitrogen freezers, since collection. Laboratory analyses will be conducted
on plasma samples from women who developed disease after donating a blood
sample and matched controls who remained disease-free, thus efficiently
utilizing these prospectively collected samples.
We will concentrate on several major hypotheses, i.e., hormonal and
nutritional determinants of disease risk. Specifically, we will examine
(1) endogenous hormone levels (estradiol [both free and bound fractions],
estrone, androgens, progesterone and prolactin) in relation to breast
cancer risk in postmenopausal women, (2) antioxidant levels in relation to
risk of breast cancer, (3) levels of folate, iron, fatty acids,
antioxidants and vitamin D in relation to both colon cancer and colon
polyps, and (4) levels of lipids, fatty acids, homocysteine, folate,
ferritin and antioxidants in relation to risk of myocardial infarction and
stroke. Most of the nutrients we propose to examine are hypothesized to
influence development of both cancer and cardiovascular disease, thus the
analyses will provide a better understanding of the influence of these
factors on overall disease risk.
The ongoing NHS will provide follow-up and documentation of cancers (CA
40356) and cardiovascular outcomes (HL 34594) in addition to information
on important covariates (such as exogenous hormone use, other dietary
factors, smoking status, and body mass index, among others) for the
proposed study. Participation in the NHS has been high: of the 121,700
women, approximately 90% continue to respond to the questionnaires, and
vital status has been documented for >98%.
Overall, the large size of the cohort, the prospective design, the high
follow-up rate, the detailed exposure data, and the availability of
archived blood specimens provide a unique opportunity to test a number of
hypotheses of public health importance.
Publications
None